Globus Medical earnings were $356.6M for the trailing 12 months ending Jun 30, 2025, with 952% growth year over year. The latest GMED earnings report on Jun 30, 2025 announced Q2 2025 earnings of $202.8M, up 168.8% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, GMED reported annual earnings of $103.0M, with -16.2% growth.
GMED past earnings growth
How has GMED's earnings growth performed historically?
On GMED's earnings call on Invalid Date, Globus Medical (NYSE: GMED) reported Q2 2025 earnings per share (EPS) of $1.50, up 552.17% year over year. Total GMED earnings for the quarter were $202.85 million. In the same quarter last year, Globus Medical's earnings per share (EPS) was $0.23.
As of the last Globus Medical earnings report, Globus Medical is currently profitable. Globus Medical's net profit (also called net income) for the twelve months ending Jun 30, 2025 was $356.65 million, a 776.83% increase year over year.
What was GMED's earnings growth in the past year?
As of Globus Medical's earnings date in Invalid Date, Globus Medical's earnings has grown 952% year over year. This is 866.93 percentage points higher than the US Medical Devices industry earnings growth rate of 85.07%. GMED earnings in the past year totalled $356.65 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.